Insider · CIK 0001773088
Anthony J Japour
Files at COCP (Cocrystal Pharma, Inc.). First filing -, latest -.
In brief
Anthony J Japour files SEC Form 4 as director at COCP (Cocrystal Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Anthony J Japour has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | COCP Cocrystal Pharma, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +16,410 | $0.00 | $0 | 16,410 | Jan 13, 2026 |
| Oct 9, 2024 | COCP Cocrystal Pharma, Inc. | AGrant or award Common Stock | +14,924 | - | - | 14,924 | Oct 11, 2024 |
Questions about Anthony J Japour
Answered from the filings on this page, as of the latest one.
Is Anthony J Japour buying or selling?
Anthony J Japour has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Anthony J Japour's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anthony J Japour has 0.
Where does Anthony J Japour file Form 4?
Anthony J Japour has filed Form 4 at COCP (Cocrystal Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.